Gholamreza Azizi Selected Research

Gholamreza Azizi Research Topics

Disease

22	Neoplasms (Cancer) 01/2022 - 10/2018
16	Multiple Sclerosis 04/2024 - 04/2013
14	Primary Immunodeficiency Diseases 11/2023 - 01/2016
13	Infections 11/2023 - 02/2017
13	Inflammation (Inflammations) 04/2022 - 12/2012
9	Rheumatoid Arthritis 01/2022 - 03/2013
8	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 09/2013
7	Agammaglobulinemia (Hypogammaglobulinemia) 05/2022 - 01/2016
7	Common Variable Immunodeficiency 02/2022 - 01/2016
7	Breast Neoplasms (Breast Cancer) 04/2020 - 10/2018
6	Reinfection 01/2022 - 01/2016
6	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2018
5	Disease Progression 01/2022 - 12/2012
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 04/2013
5	Ankylosing Spondylitis 01/2020 - 06/2015
4	Demyelinating Diseases (Demyelinating Disease) 04/2024 - 02/2014
4	IgA Deficiency 01/2023 - 01/2017
3	Eosinophilia 11/2023 - 01/2020
3	COVID-19 10/2022 - 04/2021
3	Respiratory Tract Infections (Respiratory Tract Infection) 04/2022 - 01/2019
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 06/2015
3	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2019
3	Bacterial Infections (Bacterial Infection) 01/2020 - 10/2017
2	Eczema 11/2023 - 01/2019
2	Job Syndrome (Hyper-IgE Syndrome) 11/2023 - 01/2019
2	Cytokine Release Syndrome 10/2022 - 04/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2022 - 09/2013
2	Autoimmune Lymphoproliferative Syndrome 04/2022 - 02/2022
2	Hypersensitivity (Allergy) 01/2022 - 06/2017
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 08/2015
2	Epilepsy (Aura) 01/2021 - 04/2020
2	Hypoxia (Hypoxemia) 05/2020 - 10/2018
2	Carcinogenesis 10/2019 - 01/2019
2	Poliomyelitis (Polio) 01/2018 - 01/2018
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 09/2016 - 01/2015
2	Alzheimer Disease (Alzheimer's Disease) 08/2014 - 12/2012
2	Edema (Dropsy) 03/2014 - 03/2013
2	Pain (Aches) 03/2014 - 03/2013
1	Gliosis 04/2024
1	Abscess 11/2023
1	Bone Fractures (Bone Fracture) 11/2023
1	Thrombocytosis (Thrombocythemia) 01/2023
1	Glycogen Storage Disease (Glycogenosis) 01/2023
1	Neutropenia 01/2023

Drug/Important Bio-Agent (IBA)

17	CytokinesIBA 04/2024 - 12/2012
13	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2017
10	Immunoglobulin A (IgA)IBA 08/2023 - 03/2016
10	Immunoglobulin M (IgM)IBA 12/2021 - 10/2017
9	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2017
7	Interleukin-6 (Interleukin 6)IBA 10/2022 - 10/2018
6	Immunoglobulin E (IgE)IBA 11/2023 - 06/2017
6	Immunoglobulin G (IgG)IBA 08/2023 - 01/2019
6	VaccinesIBA 10/2020 - 01/2018
6	guluronic acidIBA 04/2020 - 09/2015
5	Interleukin-22 (IL-22)IBA 05/2021 - 01/2015
5	Small Interfering RNA (siRNA)IBA 10/2020 - 10/2018
5	EnzymesIBA 11/2019 - 03/2013
4	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2018
4	Therapeutic UsesIBA 01/2018 - 06/2015
3	ChemokinesIBA 04/2024 - 08/2014
3	AntigensIBA 10/2022 - 01/2019
3	LipopolysaccharidesIBA 04/2022 - 01/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2022 - 10/2016
3	AntibodiesIBA 01/2022 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 01/2022 - 01/2019
3	InterleukinsIBA 01/2021 - 04/2014
3	chitosan lactateIBA 10/2020 - 10/2018
3	Transcription Factors (Transcription Factor)IBA 05/2020 - 05/2014
3	Adenosine (Adenocard)FDA LinkGeneric 07/2019 - 10/2018
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2022 - 05/2020
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 02/2020
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2021
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2020
2	Immune Checkpoint ProteinsIBA 10/2020 - 04/2020
2	ChitosanIBA 09/2020 - 05/2020
2	Peptides (Polypeptides)IBA 09/2020 - 10/2018
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 05/2020 - 07/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2020 - 10/2018
2	AntioxidantsIBA 04/2020 - 01/2014
2	Interleukin-4 (Interleukin 4)IBA 02/2020 - 04/2014
2	AminopeptidasesIBA 01/2020 - 10/2018
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 10/2019 - 10/2018
2	CD40 Ligand (CD40L)IBA 01/2019 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2019 - 01/2016
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2019 - 01/2019
2	D-Aspartic Acid (D Aspartate)IBA 01/2019 - 07/2017
2	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2018 - 01/2018
2	Inosine Triphosphate (ITP)IBA 09/2016 - 01/2015
2	AutoantigensIBA 01/2015 - 08/2013
2	Tyrosine Kinase InhibitorsIBA 07/2014 - 09/2013
2	Imatinib Mesylate (Gleevec)FDA Link 06/2014 - 09/2013
2	LeukotrienesIBA 03/2014 - 03/2013
2	LipidsIBA 03/2014 - 03/2013
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022

Therapy/Procedure

17	Therapeutics 04/2024 - 09/2013
7	Immunotherapy 04/2024 - 06/2017
2	Hematopoietic Stem Cell Transplantation 01/2022 - 01/2018